Supervisory board

EQS-News: Constantin Baack takes over as Chief Executive Officer of MPC Capital AG from Ulf Holländer

Retrieved on: 
Friday, May 3, 2024
Annual general meeting, MPC, Annual, CFO, Freight transport, Supervisory board, Trust, Deutsch, Ernst & Young, Management

At the end of the Annual General Meeting, Ulf Holländer will move seamlessly to the Supervisory Board, succeeding Dr. Ottmar Gast (72).

Key Points: 
  • At the end of the Annual General Meeting, Ulf Holländer will move seamlessly to the Supervisory Board, succeeding Dr. Ottmar Gast (72).
  • Constantin Baack has been with MPC Capital since 2008 and has been a member of the Management Board since 2015, responsible for the Shipping division.
  • Constantin Baack, member of the Management Board and designated CEO of MPC Capital AG: "MPC Capital stands on a very strong foundation.
  • The Management Board of MPC Capital AG will be composed as follows at the end of the Annual General Meeting on 13 June 2024: Constantin Baack (Chief Executive Officer; Chairman), Dr. Philipp Lauenstein (Chief Financial Officer) and Christian Schwenkenbecher (Chief Client Officer).

EQS-News: MorphoSys’ Management Board and Supervisory Board Recommend Shareholders Accept Public Takeover Offer by Novartis

Retrieved on: 
Friday, May 3, 2024
Cancer, EDT, MorphoSys, Takeover, ADS, Novartis, Patient, Supervisory board, Acquisition, Security (finance)

Novartis offers MorphoSys shareholders € 68.00 per share in cash, representing a total equity value of € 2.7 billion (the “Takeover Offer”).

Key Points: 
  • Novartis offers MorphoSys shareholders € 68.00 per share in cash, representing a total equity value of € 2.7 billion (the “Takeover Offer”).
  • “The offer made by Novartis provides MorphoSys shareholders with an opportunity to realize significant value upfront and with certainty.
  • MorphoSys and Novartis have agreed to delist MorphoSys shares in Germany and in the U.S. immediately after the public takeover offer has been settled.
  • The MorphoSys Management Board and Supervisory Board joint reasoned statement, as well as other relevant information for shareholders, is available on the MorphoSys website at https://www.morphosys.com/en/investors/Novartis-TakeoverOffer .

EQS-News: ecotel communication ag: Strategic change on the Management Board

Retrieved on: 
Friday, May 3, 2024
Financial management, CFO, CCO, Treasury, CPO, Business intelligence, Communication, Environment, Supervisory board, Marketing, Telecommunications, Plan, Growth, Sales, Management

The company today announced a change to and an expansion of the Management Board team.

Key Points: 
  • The company today announced a change to and an expansion of the Management Board team.
  • He has been an instrumental figure in the Sales department of ecotel communication ag since the company was founded in 1998.
  • Now that the new team is in place, the changes to the Management Board are complete.
  • We carried out the generational change, announced three years ago, in a structured and consensual manner in all departments.

EQS-News: Lenzing strengthens Managing Board with Chief Transformation Officer

Retrieved on: 
Friday, May 3, 2024
Lenzing, KUKA, Vorstand, Supervisory board, Lenzing AG, Growth, Management

Lenzing – The Supervisory Board of Lenzing AG appointed Dr. Walter Bickel as a member of the Managing Board and Chief Transformation Officer of Lenzing AG with effect from April 15, 2024 until December 31, 2025.

Key Points: 
  • Lenzing – The Supervisory Board of Lenzing AG appointed Dr. Walter Bickel as a member of the Managing Board and Chief Transformation Officer of Lenzing AG with effect from April 15, 2024 until December 31, 2025.
  • The experienced manager will strengthen the Lenzing Managing Board and will be responsible for the further development and implementation of the performance program.
  • Lenzing AG’s existing performance program was successfully initiated by the Managing Board in autumn 2023 and focuses on positive free cash flow, strengthened sales and margin growth, and sustainable cost excellence.
  • In addition, this ensures that the existing Managing Board can devote all the necessary resources to its core tasks in sales, operations and finances.

EQS-News: Make-up of the edding Group Management Board to change: from 1st June, female representation will rise to 50%

Retrieved on: 
Friday, May 3, 2024
CFO, Ministry of Finance, CDO, Edding, SME, Woman, Delhaize Group, AG, Female, Digital, Exercise, Supervisory board, CBO

Make-up of the edding Group Management Board to change: from 1st June, female representation will rise to 50%

Key Points: 
  • Make-up of the edding Group Management Board to change: from 1st June, female representation will rise to 50%
    The issuer is solely responsible for the content of this announcement.
  • The Management Board of the edding Group is set to change on 1st June 2024.
  • To ensure an immediate handover, the Supervisory Board has appointed Hadewych Vermunt, formerly CFO at Delhaize in Belgium, to the Management Board from 1st June 2024.
  • “We’re delighted to be able to welcome Hadewych Vermunt as CFO of the edding Group from 1st June”, confirms Michael Rauch, Chairperson of the Supervisory Board of edding AG.

EQS-News: Branicks Group AG: Dr. Angela Geerling elected as new Chairwoman of the Supervisory Board

Retrieved on: 
Friday, May 3, 2024
VIB, Audit committee, BBI, Supervisory board

Frankfurt, 15.04.2024 - The Supervisory Board of Branicks Group AG (Branicks), ISIN: DE000A1X3XX4, has decided on the change at its top announced at the end of last month and elected Dr. Angela Geerling as its new Chairwoman.

Key Points: 
  • Frankfurt, 15.04.2024 - The Supervisory Board of Branicks Group AG (Branicks), ISIN: DE000A1X3XX4, has decided on the change at its top announced at the end of last month and elected Dr. Angela Geerling as its new Chairwoman.
  • She has been a member of the Supervisory Board and a member of the Audit Committee since 2022.
  • The previous Chairman of the Supervisory Board, Prof. Dr. Gerhard Schmidt, will continue to be a member of the Supervisory Board and remain Chairman of the Supervisory Boards of VIB Vermögen AG and BBI Bürgerliches Brauhaus Immobilien AG.
  • She holds a doctorate in law and has worked for various real estate companies and leading law firms.

EQS-News: Nabaltec AG with a dividend proposal of EUR 0.28 per share and revenues of EUR 54.0 million in the first quarter of 2024 according to preliminary figures

Retrieved on: 
Friday, May 3, 2024
Annual general meeting, Depreciation, Chemical industry, EUR, Tax, Steel, Supervisory board, EPS, Bank statement, Film industry

In 2023, earnings before interest, taxes, depreciation and amortization (EBITDA) were EUR 31.0 million after EUR 42.4 million in 2022 (-26.9%).

Key Points: 
  • In 2023, earnings before interest, taxes, depreciation and amortization (EBITDA) were EUR 31.0 million after EUR 42.4 million in 2022 (-26.9%).
  • According to preliminary figures, Nabaltec AG achieved consolidated revenues of EUR 54.0 million for the first three months of 2024 after EUR 57.0 million in the first quarter of the previous year (-5.3%).
  • The “Specialty Oxides” product segment achieved revenues of EUR 15.4 million after EUR 17.0 million in the comparable quarter.
  • According to preliminary figures, the company achieved operating profit (EBIT) of EUR 5.0 million in the first three months of 2024 (previous year: EUR 5.2 million).

EQS-News: Evotec presents fiscal year 2023 results and announces priority reset to focus on profitable growth

Retrieved on: 
Friday, May 3, 2024
Science, Annual general meeting, EDT, Investment, PIN, Paris Agreement, EVT201, HR, Partnership, Growth, Targets, Insomnia, Webcast, Janssen, Evotec, Novartis, Science Based Targets initiative, Just, Supervisory board, Interim, BMS, Medicine, Capsule

Just – Evotec Biologics contributed € 108.4 m to the total group revenue compared to € 51.3 m in 2022, reflecting a 111% growth.

Key Points: 
  • Just – Evotec Biologics contributed € 108.4 m to the total group revenue compared to € 51.3 m in 2022, reflecting a 111% growth.
  • In March 2023, BMS and Evotec extended and expanded the neurodegeneration partnership, originally signed in 2016, for an additional eight years.
  • Evotec plans to update the market on its mid-term forecast with the release of its H1 2024 results in August 2024.
  • As part of this priority reset and in line with market developments, Evotec will simplify its reporting to Shared R&D and Just – Evotec Biologics starting Q1 2024.

EQS-News: audius publishes its annual report for 2023 and proposes a dividend of 35 cents per share

Retrieved on: 
Friday, May 3, 2024
Annual general meeting, Annual, Investment, Mobile device management, EUR, Audianism, Supervisory board, Annual report, Growth, Lithium

Today audius SE published its annual report for the past financial year, confirming the previously announced business figures.

Key Points: 
  • Today audius SE published its annual report for the past financial year, confirming the previously announced business figures.
  • According to the report, the audius Group achieved a total operating performance of EUR 78.4 million, an increase of 6% (previous year: EUR 73.4 million).
  • At EUR 7.6 million, the operating result (EBITDA) was only 4% lower than in the previous year (previous year: EUR 7.9 million).
  • The order backlog as at December 31, 2023 increased significantly once again to EUR 56.8 million (previous year: EUR 50.3 million).

EQS-News: Franz Weinberger appointed new CFO – all members of the future SIXT Management Board developed from the company's own ranks

Retrieved on: 
Friday, May 3, 2024
Sale, Annual, Corporate finance, CFO, Policy, Head, EUR, BMW, Lease, S&P, IPO, DriveNow, Hyundai, Supervisory board, BBB, Professor

Dr Franz Weinberger, trained lawyer, has been with SIXT since 2013 and is currently Head of Corporate Finance.

Key Points: 
  • Dr Franz Weinberger, trained lawyer, has been with SIXT since 2013 and is currently Head of Corporate Finance.
  • The Supervisory Board has also extended the appointments of Co-CEOs Alexander Sixt and Konstantin Sixt as well as Nico Gabriel for a further three years each.
  • Erich Sixt, Chairman of the Supervisory Board of Sixt SE: "Our future Management Board has around 70 years of profound car rental experience at SIXT.
  • At the same time, we are delighted that such a qualified successor like Franz Weinberger could be appointed, who is very familiar with SIXT.